Baricitinib Interactions
There are 512 drugs known to interact with baricitinib, along with 10 disease interactions. Of the total drug interactions, 342 are major, 160 are moderate, and 10 are minor.
- View all 512 medications that may interact with baricitinib
- View baricitinib disease interactions (10)
Most frequently checked interactions
View interaction reports for baricitinib and the medicines listed below.
- Adderall XR (amphetamine / dextroamphetamine)
- Augmentin (amoxicillin / clavulanate)
- Brevital Sodium (methohexital)
- Celebrex (celecoxib)
- Diltiazem Hydrochloride SR (diltiazem)
- Eliquis (apixaban)
- Entresto (sacubitril / valsartan)
- GamaSTAN S/D (immune globulin intramuscular)
- Gaviscon Extra Strength (aluminum hydroxide / magnesium carbonate)
- Iron Gluconate (ferrous gluconate)
- Jardiance (empagliflozin)
- L-Arginine (arginine)
- L-Carnitine (levocarnitine)
- L-Cysteine (cysteine)
- Lipitor (atorvastatin)
- Lithium Carbonate ER (lithium)
- Metoprolol Succinate ER (metoprolol)
- Metoprolol Tartrate (metoprolol)
- Morphine Sulfate ER (morphine)
- Paracetamol (acetaminophen)
- Paxlovid (nirmatrelvir / ritonavir)
- Pepcid (famotidine)
- Valproate Sodium (valproic acid)
- Vitamin B1 (thiamine)
- Vitamin B12 (cyanocobalamin)
- Vitamin B6 (pyridoxine)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Vitamin K (phytonadione)
- Vitamin K2 (menaquinone)
Baricitinib disease interactions
There are 10 disease interactions with baricitinib which include:
- infections
- tuberculosis
- cardiovascular risk
- malignancy
- thrombosis
- GI perforation
- hepatic impairment
- laboratory abnormalities
- renal dysfunction
- viral hepatitis
Report options
More about baricitinib
- baricitinib consumer information
- Compare alternatives
- Reviews (17)
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antirheumatics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Humira
Humira is a tumor necrosis factor blocker used to treat many inflammatory conditions in adults ...
Plaquenil
Plaquenil is used to treat or prevent malaria and to treat the symptoms of rheumatoid arthritis ...
Taltz
Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing ...
Paxlovid
PAXLOVID (nirmatrelvir with ritonavir) is an antiviral medication used to treat COVID-19. Includes ...
Enbrel
Enbrel is used to treat rheumatoid arthritis, ankylosing spondylitis, and psoriasis. Learn about ...
Remicade
Remicade is used to treat rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and Crohn's ...
Actemra
Actemra is used to treat COVID-19, rheumatoid arthritis, systemic juvenile idiopathic arthritis ...
Rituximab
Rituximab infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Adalimumab
Adalimumab is used to treat plaque psoriasis, Crohn's disease, ulcerative colitis, rheumatoid ...
Leflunomide
Leflunomide systemic is used for psoriatic arthritis, rheumatoid arthritis
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
